Medline Inc. is 24.7x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.99 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVCR | MDLN |
|---|---|---|
| Market cap | $1.99 B | $49.12 B |
| US-listed rank | #2110 | #329 |
| Revenue (latest FY) | $655.35M | $28.43B |
| Net income (latest FY) | -$136.23M | $1.16T |
| Net margin | -20.8% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 1,138 | 103 |
Medline Inc. is 24.7x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.99 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while Medline Inc. reported $28.43B.
Full pages: NovoCure Ltd and Medline Inc., or browse the full rankings.